🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Andrew N. Freedman

National Institutes of Health

ORCID: 0000-0003-1451-4208

Also affiliated with United States Food and Drug Administration, National Cancer Institute

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile
1.7Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Epidemiologic Research of Rare Cancers: Trends, Resources, and Challenges

Cancer Epidemiology Biomarkers & Prevention(2021)10.1158/1055-9965.epi-20-1796
Top 16%
1.3DataRank
Top 16%27 citations

Danielle Daee, Melissa Rotunno, Rolando Barajas, Sarah Fagan, Danielle M. Carrick +10 more

Papers

Driven by 10 papers — median percentile 70. Top paper: “Potential increased risk of cancer from commonly used medications: an umbrella review of meta-analyses”.

Potential increased risk of cancer from commonly used medications: an umbrella review of meta-analyses

Annals of Oncology(2014)10.1093/annonc/mdt372
N/A
2.2DataRank · unranked
51 citations

Y. Zhou, C.Q. Chang, M.J. Khoury, John P. A. Ioannidis, Yuanliang Zhou +4 more

Epidemiologic Research of Rare Cancers: Trends, Resources, and Challenges

Cancer Epidemiology Biomarkers & Prevention(2021)10.1158/1055-9965.epi-20-1796
Top 16%
1.3DataRank
Top 16%27 citations

Danielle Daee, Melissa Rotunno, Rolando Barajas, Sarah Fagan, Danielle M. Carrick +10 more

Revised Bethesda Guidelines for Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) and Microsatellite Instability

JNCI Journal of the National Cancer Institute(2004)10.1093/jnci/djh034
N/A
1.2DataRank · unranked
3172 citations

C. R. Boland, J. P. Terdiman, S. Syngal, J. Ruschoff, R. Fishel +36 more

Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration

European Journal of Clinical Investigation(2011)10.1111/j.1365-2362.2011.02493.x
N/A
0.553DataRank · unranked
39 citations

John P. A. Ioannidis, Sara Bedrosian, Jonine L. Bernstein, Siobhan M. Dolan, Isabel Fortier +20 more

Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration

European Journal of Human Genetics(2011)10.1038/ejhg.2011.27
N/A
0.533DataRank · unranked
34 citations

Sara Bedrosian, Jonine L. Bernstein, Siobhan M. Dolan, Isabel Fortier, Andrew N. Freedman +21 more

NCI-Funded Cancer Epidemiology Survivor Cohorts: Overview, Progress, and Opportunities

Cancer Epidemiology Biomarkers & Prevention(2025)10.1158/1055-9965.epi-24-1750
Top 44%
0.418DataRank
Top 44%4 citations

Andrea N. Burnett‐Hartman, Kelly K. Filipski, Nonniekaye Shelburne, Andrew N. Freedman, Lisa Gallicchio

The National Cancer Institute and Cannabis and Cannabinoids Research

JNCI Monographs(2021)10.1093/jncimonographs/lgab014
N/A
0.330DataRank · unranked
8 citations

Luis Alejandro Salicrup, Andrew N. Freedman, Yali Fu, Sharon R. Ross, Ronald L. Johnson +3 more

Involving patients and their families in deciding to use next generation sequencing: Results from a nationally representative survey of U.S. oncologists

UNC Libraries(2023)10.17615/s8h4-fe56
N/A
0DataRank · unranked
0 citations

William M. P. Klein, L.P. Spees, Irene Prabhu Das, Michael C. Roberts, Andrew N. Freedman +2 more

Importance of Patient Health Insurance Coverage and Out-of-Pocket Costs for Genomic Testing in Oncologists' Treatment Decisions

JCO Oncology Practice(2024)10.1200/op.23.00153
N/A
0DataRank · unranked
12 citations

Kewei Sylvia Shi, Jingxuan Zhao, Andrew N. Freedman, Zhiyuan Zheng, Letícia Nogueira +4 more

Strengthening the reporting of Genetic RIsk Prediction Studies (GRIPS): explanation and elaboration

UNC Libraries(2020)10.17615/6gxv-vj18
N/A
0DataRank · unranked
0 citations

John P. A. Ioannidis, Sara Bedrosian, Jonine L. Bernstein, Siobhan M. Dolan, Nicole F. Dowling +20 more